Remibrutinib in Sjogren's Syndrome Dr. Michael Putman reports on abstract 1113 presented at ACR22. Abstract 1113: Remib
Tweet Content
Remibrutinib in Sjogren's Syndrome
Dr. Michael Putman reports on abstract 1113 presented at ACR22. Abstract 1113: Remibrutinib (LOU064) in Sjögren’s Syndrome: Safety and Efficacy Results from a 24‑Week Placebo-controlled Proof-of-Concept Study
https://t.co/4UAxMq2z0X https://t.co/kzinfgDGZr
Links
Show on Archive Page
On
Display in Search Results
On
PDQ
Off